| The concomitant occurrence of JAK2V617F mutation and BCR/ABL transcript with phenotypic expression–an overlapping myeloproliferative disorder or two distinct diseases?-case report I Ursuleac, AC Colita, T Adam, C Jardan, A Ilea, D Coriu Journal of Medicine and Life 6 (1), 34, 2013 | 16 | 2013 |
| In situ” mantle cell lymphoma associated with hyaline-vascular Castleman disease C Dobrea, M Mihai, E Dănăilă, A Găman, D Coriu, I Ursuleac Rom J Morphol Embryol 52 (3 Suppl), 1147-1151, 2011 | 10 | 2011 |
| Littoral cell angioma of the spleen-a surprising cause of anemia I Ursuleac, C Iosif, R Birla, C Dobrea, AM Gaman, D Arsene Rom J Morphol Embryol 54 (3 Suppl), 885-8, 2013 | 9 | 2013 |
| Real-world clinical outcomes and adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib: a single-center retrospective study AM Moldovianu, R Stoia, M Vasilica, I Ursuleac, SN Badelita, AA Tomescu, ... Medicina 59 (2), 324, 2023 | 5 | 2023 |
| Paroxysmal nocturnal hemoglobinuria: Pandora’s box? MA Găman, I Ursuleac, D Coriu Journal of Mind and Medical Sciences 7 (2), 245-249, 2020 | 4 | 2020 |
| Clinical and hematological aspects of chronic myelomonocytic leukemia. Study on 20 cases from a single center from Romania. R Gologan, A Berceanu, A Colita, V Codreanu, C Dobrea, L Geoada, ... Romanian Journal of Internal Medicine= Revue Roumaine de Medecine Interne 40 …, 2002 | 3 | 2002 |
| Translation, Cultural Adaptation, and Validation into Romanian of the Myeloproliferative Neoplasm Symptom Assessment Form—Total Symptom Score (MPN-SAF TSS or MPN-10) Questionnaire MA Găman, RM Scherber, I Ursuleac, AM Crişan, SN Bădeliţă, ... Journal of Clinical Medicine 13 (11), 3284, 2024 | 1 | 2024 |
| Essential thrombocythemia: one-center data in a changing disease N Pirciulescu, MA Gaman, M Mihailescu, C Constantin, M Dragomir, ... Medicina 58 (12), 1798, 2022 | 1 | 2022 |
| PARTICULARITĂŢILE DIAGNOSTICULUI DE LABORATOR ÎN HAIRY CELL LEUKEMIA. VC Moraru Romanian Medical Journal 59 (1), 2012 | 1 | 2012 |
| HAIRY CELL LEUKEMIA CLINICO-EVOLUTIVE ASPECTS AT 73 PATIENTS ADMITTED IN FUNDENI CLINIC OF HEMATOLOGY BETWEEN 2000-2008. I Ursuleac, L Barsan, V Moraru, A Tatic, C Dobrea, O Georgescu, A Colita, ... TRANSFUSION HAEMATOLOGY 48, 53, 0 | 1 | |
| VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG) E Kastritis, M Beksac, SN Badelita, E Katodritou, J Bila, E Spanoudakis, ... Clinical Lymphoma Myeloma and Leukemia, 2024 | | 2024 |
| Complications of Brentuximab Therapy in Patients with Hodgkin’s Lymphoma and Concurrent Autoimmune Pathology—A Case Series OD Preda, S Bădeliță, I Ursuleac, RM Irimia, S Balanica, M Cojocaru, ... Hematology Reports 16 (2), 299-307, 2024 | | 2024 |
| Real-Life Data, a Retrospective Report from Romania Hodgkin’s Lymphoma Registry-Single Center Experience OD PREDA, S BADELITA, I URSULEAC, R STOIA, M VASILICA, ... Revista Romana de Hematologie 2 (2), 2024 | | 2024 |
| Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-Lenalidomide-Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the … E Kastritis, M Beksac, SN Badelita, E Katodritou, J Bila, E Spanoudakis, ... Blood 142, 4734, 2023 | | 2023 |
| An unusual presentation of blastic plasmacytoid dendritic cell neoplasm with bone marrow and skin involvement D Enea, I Ursuleac, C Popa, C Dobrea VIRCHOWS ARCHIV 479, S254-S255, 2021 | | 2021 |
| MPN-340: Are There Any Age Differences in the Response to and Hematological Side Effects of Ruxolitinib Treatment in Myelofibrosis? MA Gaman, RA Stoia, C Constantin, A Trifu, D Coriu, I Ursuleac Clinical Lymphoma Myeloma and Leukemia 20, S337, 2020 | | 2020 |
| Secondary Acute Myeloid Leukemia Following Myeloproliferative Neoplasms–A Unicentric Study A Trifu, C Constantin, M Dragomir, S Aposteanu, C Dobrea, D Coriu, ... Clinical Lymphoma, Myeloma and Leukemia 19, S227, 2019 | | 2019 |
| PB2040 EMERGENT INFECTIONS ASSOCIATED TO THE TREATMENT WITH NEW MOLECULES IN CHRONIC LYMPHOCYTIC LEUKEMIA-SINGLE CENTER EXPERIENCE AA Tomescu, A Enache, R Dragan, M Vasilica, D Coriu, I Ursuleac HemaSphere 3 (S1), 921, 2019 | | 2019 |
| MINIMIZING THE RISK OF MUCOSITIS IN HEMATOLOGIC PATIENTS WITH TOPICAL PRODUCTS I Ursuleac, Z Varady, A Enache, AA Tomescu, R Dragan, D Coriu HAEMATOLOGICA 102, 844-844, 2017 | | 2017 |
| THE ROLE OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-R) IN THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA OF ADULT-THE EXPERIENCE OF FUNDENI CLINIC OF HEMATOLOGY I Ursuleac, AC Colita, M Vasilica, RA Stoia, D Coriu HAEMATOLOGICA 99, 771-771, 2014 | | 2014 |
